Related Experiment Video
Updated: Jan 20, 2026

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
Published on: January 31, 2020
Abacavir-based Regimen for HIV-infected Children and Adolescents
Prince Pareek1, D K Singh2, Ruchi Rai1
1Department of Pediatrics, MLN Medical College, Allahabad, Uttar Pradesh, India.
Abstract:
We studied 48 children receiving abacavir-based HAART regimen, over a period of one-year for side effects and failure rates. None of the children developed hypersensitivity reaction. The CD4 count significantly improved from the time of enrolment till 12 months of therapy while the failure rate was 14.5%.
Related Concept Videos
08:15Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
10:24SILAC Based Proteomic Characterization of Exosomes from HIV-1 Infected Cells
06:07Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
11:38Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model
11:10Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3
03:13Establishing an Active HIV Infection in a Rat Model

